Moderna (MRNA) News Today $27.47 -0.17 (-0.62%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$27.54 +0.08 (+0.27%) As of 04:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Moderna Down Today?Toggle Visibility of Why Is Moderna Down Today?Moderna (MRNA) stock movement today reflects a mix of regulatory wins, corporate ratings changes, earnings results, and government funding adjustments. Positive Sentiment: UK Court of Appeal confirms Moderna’s EP’949 patent valid, ruling Pfizer/BioNTech infringed UK Court Patent Decision Neutral Sentiment: Oppenheimer maintains a Hold rating on Moderna shares Oppenheimer Hold Rating Neutral Sentiment: Q2 results show EPS beat ($2.13 vs. $2.99 loss expected) and revenue topped estimates ($142M vs. $116.3M) but revenue fell 41% year-over-year Q2 Earnings Report Neutral Sentiment: Seeking Alpha notes Q2 downsizing triggered a selloff but remains long-term bullish on Moderna SA Long-Term Bullish View Negative Sentiment: Kennedy Jr. says US Health Department will halt $500M funding for mRNA vaccine projects Firstpost Article Negative Sentiment: HHS cuts funding for mRNA vaccine development MSN Health Article Negative Sentiment: RFK Jr. pulls $500M in mRNA vaccine contracts MSN Politics Article Negative Sentiment: RFK Jr. halts $500M for mRNA vaccine research MSN Health Other Article Negative Sentiment: Barclays lowers price target on MRNA to $31 from $40 and assigns Equal Weight MarketBeat Article Negative Sentiment: Barclays issues pessimistic forecast for Moderna shares American Banking News Negative Sentiment: Leerink Partners rates MRNA a Sell G&M Sell Rating Negative Sentiment: Analyst warns RSV vaccine upside is limited and cash burn remains heavy SA RSV Outlook Posted 4h agoAI Generated. May Contain Errors. MRNA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Envestnet Asset Management Inc. Sells 12,212 Shares of Moderna, Inc. (NASDAQ:MRNA)2 hours ago | marketbeat.comHHS slashes funding for mRNA vaccine development5 hours ago | msn.comRFK Jr. pulls $500 million in funding for mRNA vaccine contracts5 hours ago | msn.comRFK Jr. halts $500 million for mRNA vaccine research5 hours ago | msn.comBarclays Has Lowered Expectations for Moderna (NASDAQ:MRNA) Stock PriceAugust 5 at 1:49 PM | marketbeat.comModerna (MRNA) Receives a Sell from Leerink PartnersAugust 5 at 11:18 AM | theglobeandmail.comOppenheimer Remains a Hold on Moderna (MRNA)August 5 at 11:18 AM | theglobeandmail.comModerna: RSV Upside Slim, Cash Burn HeavyAugust 5 at 11:18 AM | seekingalpha.comLPL Financial LLC Boosts Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)August 5 at 3:45 AM | marketbeat.comBarclays Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock PriceAugust 5 at 3:13 AM | americanbankingnews.comUK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTechAugust 4 at 1:10 PM | usatoday.comModerna Q2 Earnings Review: Downsizing Triggers Selloff, But I'm Long-Term BullishAugust 4 at 9:33 AM | seekingalpha.comModerna (NASDAQ:MRNA) Announces Quarterly Earnings ResultsAugust 4 at 8:30 AM | marketbeat.comBanco Santander S.A. Acquires 43,296 Shares of Moderna, Inc. (NASDAQ:MRNA)August 4 at 6:55 AM | marketbeat.comOVERSEA CHINESE BANKING Corp Ltd Has $1.16 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)August 4 at 6:53 AM | marketbeat.comMoors & Cabot Inc. Has $575,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)August 4 at 5:01 AM | marketbeat.comXTX Topco Ltd Raises Position in Moderna, Inc. (NASDAQ:MRNA)August 4 at 4:49 AM | marketbeat.comBanque Cantonale Vaudoise Acquires New Stake in Moderna, Inc. (NASDAQ:MRNA)August 3 at 5:15 AM | marketbeat.comModerna Sees Unusually High Options Volume (NASDAQ:MRNA)August 2, 2025 | marketbeat.comModerna (NASDAQ:MRNA) Shares Gap Down - Time to Sell?August 2, 2025 | marketbeat.comModerna is laying off 10% of its workforce. Does RFK Jr. have anything to do with it?August 2, 2025 | msn.comModerna, Inc. (NASDAQ:MRNA) Q2 2025 Earnings Call TranscriptAugust 2, 2025 | msn.comWealthquest Corp Takes $1.04 Million Position in Moderna, Inc. (NASDAQ:MRNA)August 2, 2025 | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Shares Acquired by Federated Hermes Inc.August 2, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Has $5.45 Million Position in Moderna, Inc. (NASDAQ:MRNA)August 2, 2025 | marketbeat.comPacer Advisors Inc. Cuts Stock Position in Moderna, Inc. (NASDAQ:MRNA)August 2, 2025 | marketbeat.comModerna cuts sales forecast on UK revenue delay, shares fallAugust 1, 2025 | reuters.comWhy Moderna (MRNA) Stock Is Trading Lower TodayAugust 1, 2025 | finance.yahoo.comModerna, Inc. (MRNA) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | seekingalpha.comModerna, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 1, 2025 | seekingalpha.comModerna slashes full-year sales outlook, reduces headcountAugust 1, 2025 | proactiveinvestors.comModerna Stock Drops as Firm Cuts Revenue Outlook on UK Vaccine Deliveries DelayAugust 1, 2025 | investopedia.comModerna: Q2 Earnings SnapshotAugust 1, 2025 | sfgate.comModerna lowers top end of revenue guidance as vaccine group targets cost cutsAugust 1, 2025 | finance.yahoo.comModerna Logs Sales Beat Despite Declining Vaccine DemandAugust 1, 2025 | msn.comModerna Stock Dives After Earnings Report. What Has Wall Street Worried.August 1, 2025 | msn.comModerna drops after narrowing 2025 revenue outlookAugust 1, 2025 | msn.comModerna (NASDAQ:MRNA) Exceeds Q2 Expectations But Stock DropsAugust 1, 2025 | finance.yahoo.comModerna Stock Drops After Earnings Report. What Has Wall Street Worried.August 1, 2025 | barrons.comModerna quarterly sales beat Street estimates on COVID booster sales, cost cutsAugust 1, 2025 | reuters.comModerna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.August 1, 2025 | cnbc.comPfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent winAugust 1, 2025 | reuters.comModerna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallAugust 1, 2025 | benzinga.comPrivate Advisor Group LLC Sells 13,174 Shares of Moderna, Inc. (NASDAQ:MRNA)August 1, 2025 | marketbeat.comModerna Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings CallAugust 1, 2025 | benzinga.comMore than 800 Moderna employees will lose their jobs this year as costs are slashedAugust 1, 2025 | msn.comModerna plans to slash 10% of workforce as COVID shot sales slowJuly 31, 2025 | msn.comModerna to lay off 10% of staff this yearJuly 31, 2025 | msn.comModerna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sinkJuly 31, 2025 | msn.com7MRNA : Moderna's Earnings: A PreviewJuly 31, 2025 | benzinga.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.220.45▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼6125▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRISPR Therapeutics News CureVac News Robinhood Markets News Novavax News Ocugen News Tesla News Johnson & Johnson News Merck & Co., Inc. News Pfizer News argenex News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
